3C PATCH® REIMBURSEMENT
3C Patch® System is an FDA-cleared advanced wound management solution
Currently covered by CMS in all 50 States in the US
Medicare Code – G0460
Ambulatory Payment Classification – 5054
National Average Payment – $1.622.74
FOR MORE INFORMATION AND PRODUCT PRICING
Scientific and clinical data support the effect of 3C Patch® in wound management, compared to standard of care.
The 3C Patch® System is cleared by the FDA for the management of exuding wounds, such as leg ulcers, pressure ulcers, diabetic ulcers, and mechanically or surgically debrided wounds.
CE MARKED IN EUROPE
The intended use of the 3C Patch® Device is to produce an autologous platelet-rich fibrin for wound management of recalcitrant wounds.